A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic

Dahima Cintron, Caitlan Pinotti, Jennifer L Rogers, Kai Sun, Rebecca Sadun, Mithu Maheswaranathan, Jayanth Doss, Lisa Criscione-Schreiber, Megan E.B. Clowse, Division of Rheumatology, Duke University Medical Center, Pediatric Rheumatology, Duke University Medical Center, Pediatric Rheumatology, University of North Carolina, Chapel Hill

Lupus: An International Journal

Published online on June 04, 2026

Abstract

Lupus, Volume 35, Issue 9, Page 956-964, August 2026.
Background/PurposeMycophenolate compound (MMF, to represent both mycophenolate mofetil and mycophenolic acid) is an immunosuppressant used to treat Systemic Lupus Erythematosus (SLE). Due to its teratogenicity, the FDA recommends universal mycophenolate ...